Trial of PM02734 Administered in Combination With Erlotinib in Patients With Advanced Malignant Solid Tumors

Clinical trial NCT00884845 · COMPLETED

Trial details

NCT number: NCT00884845
Sponsor: PharmaMar
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Solid Tumors

Start date: 2009-01-01
Primary completion: 2011-06-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.